Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy.
Breast cancer research and treatment（2023）
摘要
This study was registered at the UMIN Clinical Trials Registry under UMIN000001090 (registered 20 March 2008).
更多查看译文
关键词
Chemotherapy,Clinical trial,Early breast cancer,Neoadjuvant endocrine therapy,Response-guided therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要